ALNY logo

Alnylam Pharmaceuticals (ALNY) Book value

annual book value:

$67.09M+$287.73M(+130.41%)
December 31, 2024

Summary

  • As of today (April 18, 2025), ALNY annual book value is $67.09 million, with the most recent change of +$287.73 million (+130.41%) on December 31, 2024.
  • During the last 3 years, ALNY annual book value has fallen by -$521.12 million (-88.59%).
  • ALNY annual book value is now -96.20% below its all-time high of $1.77 billion, reached on December 31, 2017.

Performance

ALNY Book value Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherALNYbalance sheet metrics

quarterly book value:

$67.09M+$34.73M(+107.36%)
December 31, 2024

Summary

  • As of today (April 18, 2025), ALNY quarterly book value is $67.09 million, with the most recent change of +$34.73 million (+107.36%) on December 31, 2024.
  • Over the past year, ALNY quarterly book value has increased by +$287.73 million (+130.41%).
  • ALNY quarterly book value is now -96.20% below its all-time high of $1.77 billion, reached on December 31, 2017.

Performance

ALNY quarterly book value Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherALNYbalance sheet metrics

Book value Formula

Book Value = Total Assets − Total Liabilities

ALNY Book value Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+130.4%+130.4%
3 y3 years-88.6%+130.4%
5 y5 years-95.3%+130.4%

ALNY Book value Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-88.6%+130.4%-83.3%+116.4%
5 y5-year-95.3%+130.4%-95.2%+116.4%
alltimeall time-96.2%+130.4%-96.2%+116.4%

Alnylam Pharmaceuticals Book value History

DateAnnualQuarterly
Dec 2024
$67.09M(-130.4%)
$67.09M(+107.4%)
Sep 2024
-
$32.35M(-1154.9%)
Jun 2024
-
-$3.07M(-98.6%)
Mar 2024
-
-$219.27M(-0.6%)
Dec 2023
-$220.64M(+39.5%)
-$220.64M(+33.0%)
Sep 2023
-
-$165.87M(-59.4%)
Jun 2023
-
-$408.13M(+57.4%)
Mar 2023
-
-$259.24M(+63.8%)
Dec 2022
-$158.22M(-126.9%)
-$158.22M(+133.9%)
Sep 2022
-
-$67.64M(-138.4%)
Jun 2022
-
$176.04M(-56.1%)
Mar 2022
-
$401.17M(-31.8%)
Dec 2021
$588.20M(-42.1%)
$588.20M(-22.2%)
Sep 2021
-
$755.89M(-11.4%)
Jun 2021
-
$853.36M(-7.9%)
Mar 2021
-
$926.19M(-8.9%)
Dec 2020
$1.02B(-29.4%)
$1.02B(-16.4%)
Sep 2020
-
$1.22B(-13.2%)
Jun 2020
-
$1.40B(+3.7%)
Mar 2020
-
$1.35B(-6.2%)
Dec 2019
$1.44B(+10.5%)
$1.44B(-10.5%)
Sep 2019
-
$1.61B(-8.5%)
Jun 2019
-
$1.76B(+13.6%)
Mar 2019
-
$1.55B(+18.8%)
Dec 2018
$1.30B(-26.3%)
$1.30B(-11.9%)
Sep 2018
-
$1.48B(-8.8%)
Jun 2018
-
$1.62B(-7.6%)
Mar 2018
-
$1.75B(-0.7%)
Dec 2017
$1.77B(+92.0%)
$1.77B(+66.8%)
Sep 2017
-
$1.06B(-5.7%)
Jun 2017
-
$1.12B(+35.2%)
Mar 2017
-
$830.90M(-9.7%)
Dec 2016
$920.22M(-27.2%)
$920.22M(-9.3%)
Sep 2016
-
$1.01B(-7.6%)
Jun 2016
-
$1.10B(-7.6%)
Mar 2016
-
$1.19B(-6.0%)
Dec 2015
$1.26B(+35.1%)
$1.26B(-4.3%)
Sep 2015
-
$1.32B(-6.2%)
Jun 2015
-
$1.41B(-5.9%)
Mar 2015
-
$1.50B(+59.8%)
Dec 2014
$936.27M
$936.27M(+3.5%)
Sep 2014
-
$904.48M(-4.0%)
Jun 2014
-
$942.27M(-1.3%)
DateAnnualQuarterly
Mar 2014
-
$954.97M(+253.2%)
Dec 2013
$270.35M(+101.7%)
$270.35M(-9.2%)
Sep 2013
-
$297.58M(-3.4%)
Jun 2013
-
$308.18M(-1.1%)
Mar 2013
-
$311.56M(+132.4%)
Dec 2012
$134.05M(+13.6%)
$134.05M(-24.3%)
Sep 2012
-
$177.16M(-5.9%)
Jun 2012
-
$188.29M(-4.6%)
Mar 2012
-
$197.38M(+67.3%)
Dec 2011
$118.00M(-25.4%)
$118.00M(-7.7%)
Sep 2011
-
$127.87M(-6.4%)
Jun 2011
-
$136.55M(-6.2%)
Mar 2011
-
$145.57M(-8.0%)
Dec 2010
$158.23M(-11.1%)
$158.23M(-1.5%)
Sep 2010
-
$160.64M(-2.9%)
Jun 2010
-
$165.48M(-3.7%)
Mar 2010
-
$171.83M(-3.4%)
Dec 2009
$177.97M(-12.0%)
$177.97M(-2.2%)
Sep 2009
-
$182.02M(-1.3%)
Jun 2009
-
$184.48M(-7.2%)
Mar 2009
-
$198.74M(-1.7%)
Dec 2008
$202.13M(+1.5%)
$202.13M(-1.2%)
Sep 2008
-
$204.56M(+2.7%)
Jun 2008
-
$199.17M(-1.8%)
Mar 2008
-
$202.81M(+1.8%)
Dec 2007
$199.17M(-1.0%)
$199.17M(+3.2%)
Sep 2007
-
$192.94M(+7.6%)
Jun 2007
-
$179.27M(-5.7%)
Mar 2007
-
$190.03M(-5.5%)
Dec 2006
$201.17M(+225.6%)
$201.17M(+92.0%)
Sep 2006
-
$104.78M(-4.8%)
Jun 2006
-
$110.08M(-6.6%)
Mar 2006
-
$117.92M(+90.9%)
Dec 2005
$61.78M(+33.9%)
$61.78M(+167.8%)
Sep 2005
-
$23.07M(-21.5%)
Jun 2005
-
$29.39M(-26.2%)
Mar 2005
-
$39.83M(-13.7%)
Dec 2004
$46.14M(-272.8%)
$46.14M(+2.6%)
Sep 2004
-
$44.98M(-11.2%)
Jun 2004
-
$50.67M(-229.7%)
Mar 2004
-
-$39.08M(+46.3%)
Dec 2003
-$26.71M(+474.8%)
-$26.71M
Dec 2002
-$4.65M
-

FAQ

  • What is Alnylam Pharmaceuticals annual book value?
  • What is the all time high annual book value for Alnylam Pharmaceuticals?
  • What is Alnylam Pharmaceuticals annual book value year-on-year change?
  • What is Alnylam Pharmaceuticals quarterly book value?
  • What is the all time high quarterly book value for Alnylam Pharmaceuticals?
  • What is Alnylam Pharmaceuticals quarterly book value year-on-year change?

What is Alnylam Pharmaceuticals annual book value?

The current annual book value of ALNY is $67.09M

What is the all time high annual book value for Alnylam Pharmaceuticals?

Alnylam Pharmaceuticals all-time high annual book value is $1.77B

What is Alnylam Pharmaceuticals annual book value year-on-year change?

Over the past year, ALNY annual book value has changed by +$287.73M (+130.41%)

What is Alnylam Pharmaceuticals quarterly book value?

The current quarterly book value of ALNY is $67.09M

What is the all time high quarterly book value for Alnylam Pharmaceuticals?

Alnylam Pharmaceuticals all-time high quarterly book value is $1.77B

What is Alnylam Pharmaceuticals quarterly book value year-on-year change?

Over the past year, ALNY quarterly book value has changed by +$287.73M (+130.41%)
On this page